Comparison of effectiveness of bleomycin and triamcinolone acetonide intralesional injections in the treatment of keloids.
Not Applicable
- Conditions
- Health Condition 1: L910- Hypertrophic scar
- Registration Number
- CTRI/2023/09/057988
- Lead Sponsor
- Dr Divya Ravali Bandaru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with clinically diagnosed keloid present on trunk, aged above 18 years and willing for regular follow-up.
Exclusion Criteria
Active inflammation, infection or ulcer in or around the keloid.
Patients who received treatment for the same keloid in the past six months
Pregnancy, lactation, chronic renal failure, bleeding tendencies.
Those who develop a hypersensitive or an idiosyncratic reaction to bleomycin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in the height, vascularity, pliability and pigmentation of keloid assessed using Vancouver Scar Scale.Timepoint: Keloid assessed at the time of diagnosis, and followed up every 4 weeks.
- Secondary Outcome Measures
Name Time Method Reduction in pruritis & painTimepoint: At the time of diagnosis & followed up every 4 weeks